The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed several hundreds of thousands of people in the last two decades.

Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday.

A settlement agreement with Purdue Pharma and members of the Sackler family, could bring in another $250 million to New York state, some of which will help bolster harm reduction, treatment and recovery programs in New York City.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller. Massachusetts Attorney General Andrea Campbell said that the state could receive up to $108 million of the settlement money.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction crisis in the U.

The deal, agreed to by Purdue Pharma, the Sackler family members who ... resources to communities in need so that we can heal,” New York Attorney General Letitia James said.

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.